KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.

Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
The public health emergency has prompted international health agencies, including the World Health Organization, to support local medical teams with logistics, laboratory testing, and vaccine distribution. Authorities are administering the Ervebo vaccine under a compassionate-use framework while medical researchers gather observational data on its effectiveness against the viral strain circulating in the region. DR Congo launches Ebola vaccination campaign as health workers intensify ring-vaccination strategies around identified infection clusters to isolate viral transmission chains.
Health Ministry Focuses on Ervebo Doses for Medical Staff in Kisangani
Operational challenges hinder logistical efforts due to complex regional infrastructure, ongoing security issues, and high population movement across border districts. Cold-chain supply systems have been put in place in Kisangani to ensure the vaccine remains at ultra-low temperatures before reaching remote health zones. DR Congo begins Ebola vaccination efforts as civil defense and community health workers conduct outreach to improve disease monitoring and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention team up with local units to monitor adverse reactions and assess immune responses among vaccinated populations. Officials stressed that early clinical detection, combined with isolation and supportive treatments, remains vital to increasing patient survival chances. More vaccine shipments are planned to expand distribution across secondary health districts.
Authorities Enforce Rigid Infection Control Protocols in Treatment Centers
National teams continue broadening contact-tracing efforts in urban and rural areas of the eastern region. Local health clinics are supplied with personal protective equipment, diagnostic reagents, and treatment supplies to boost readiness. Government agencies confirmed that all public health measures will stay in place until viral transmission rates show consistent decline across the affected provinces.
The government called on local populations to cooperate with mobile vaccination teams and follow sanitary guidelines. It is expected that increasing immunization among high-risk groups will help stabilize infection levels over the upcoming weeks. Monitoring networks will stay alert at transportation hubs and border crossings to prevent further spread of the virus.
